Literature DB >> 24762226

Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression.

Zhang Ye1, Li Jingzhong, Liu Yangbo, Chen Lei, Yuan Jiandong.   

Abstract

Propofol is one of the extensively commonly used intravenous anesthetic agents. Previous studies have indicated that propofol has the ability to influence the biological behavior of several human cancer cells. However, the effect of propofol on osteosarcoma and its related molecular mechanisms are still not clear. Here we found that propofol significantly elevated the expression of miR-143, inhibited cell proliferation and invasion, and promoted apoptosis in osteosarcoma cell line MG63. Propofol also efficiently decreased protein expression of matrix metalloproteinase 13 (MMP-13). Moreover, the overexpression of miR-143 decreased MMP-13 protein level. Finally, the neutralization of miR-143 by anti-miR-143 antibody reversed the effect of propofol on cell proliferation, apoptosis, and invasion and upregulated MMP-13 expression in MG63 cells. Taken together, propofol may have antitumor potential in osteosarcoma, which is partly due to the downregulation of MMP-13 expression by miR-143.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24762226     DOI: 10.3727/096504014X13890370410203

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  31 in total

1.  MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.

Authors:  Xinzhen Guo; Jie Zhang; Jianfeng Pang; Sheng He; Guojun Li; Yang Chong; Chao Li; Zhijian Jiao; Shiqian Zhang; Ming Shao
Journal:  Tumour Biol       Date:  2016-01-14

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.

Authors:  Tonggang Liu; Xuezhong Zhang; Kaihui Sha; Xianxian Liu; Liguo Zhang; Bangmao Wang
Journal:  Cell Prolif       Date:  2015-03-27       Impact factor: 6.831

4.  Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome c pathways.

Authors:  Xiong Min; Han Heng; Hua-Long Yu; Mao Dan; Chen Jie; Yun Zeng; He Ning; Zhi-Gang Liu; Zhi-Yong Wang; Wang Lin
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 5.  MicroRNA expression and its clinical implications in Ewing's sarcoma.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; William Ka Kei Wu; Matthew T V Chan
Journal:  Cell Prolif       Date:  2014-12-22       Impact factor: 6.831

6.  Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.

Authors:  Martina Argano; Raffaella De Maria; Katrin Rodlsberger; Paolo Buracco; M Paula Larenza Menzies
Journal:  Can J Vet Res       Date:  2019-04       Impact factor: 1.310

7.  miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.

Authors:  Guangfeng Niu; Bin Li; Jianmin Sun; Li Sun
Journal:  Cell Prolif       Date:  2015-04-16       Impact factor: 6.831

8.  Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.

Authors:  Wei Ou; Jie Lv; Xiaohua Zou; Yin Yao; Jinli Wu; Jian Yang; Zhumei Wang; Yan Ma
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

Review 9.  Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis.

Authors:  Julia A Dubowitz; Erica K Sloan; Bernhard J Riedel
Journal:  Clin Exp Metastasis       Date:  2017-09-11       Impact factor: 5.150

Review 10.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.